Quantum Biopharma Ltd (HUGE) Return on Assets ROA from the third quarter of 2025 to third quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Sep 30 2025 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quantum Biopharma Ltd   (NASDAQ: HUGE)


Quantum Biopharma Ltd 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Quantum Biopharma Ltd 's ROA in the third quarter of 2025?
Quantum Biopharma Ltd recorded a cumulative net loss of $-37 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -270.03%.

However, within the Healthcare sector 830 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2025 from to 5115.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter
Y / Y Total Assets Change -49.39 % -26.56 % -21.81 % 19.43 % 25.81 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -37 -37 -30 -24 -27
Return On Assets (TTM) -270.03 % -221.31 % -169.58 % -124.93 % -149.23 %
HUGE's Total Ranking # 5115 # # # # 5474
Total Assets (TTM) in million 11 14 15 15 22
Seq. Total Assets Change -21.14 % -7.48 % 2.85 % -32.56 % 14.43 %
Seq. Net Income Change - - - - -

HUGE's 5 Years Annual ROA >> Back to HUGE Management Effectiveness >> Compare HUGE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 390
Sector # 831
Overall # 5039

Return On Assets Statistics
High Average Low
-56.04 %
-75.74 %
-102.45 %
(Dec 31 2021)   (Dec 31 2023)





Financial Statements
Quantum Biopharma Ltd 's Assets $ 11 million HUGE's Balance sheet
Quantum Biopharma Ltd 's Income $ -5 million Quarterly HUGE's Income Statement
HUGE's Income by Division See HUGE's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change -64.72 % -3.4 % -26.34 % -50.9 % 103.99 %
Total Assets in million 8 22 23 31 63
Y / Y Net Income Change - - - - -
Net Income in million -14 -18 -24 -35 -32
Annual Return On Assets -182.56 % -81.18 % -103.4 % -113.84 % -50.37 %

HUGE's 5 Years Annual ROA >> Back to HUGE Management Effectiveness >> Compare HUGE ROA to its Competitors



More Return On Assets Ratios
HUGE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HUGE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HUGE's Competitors
Subscribers only: Roa for Quantum Biopharma Ltd 's Suppliers
Subscribers only: Return On Assets for HUGE's Customers

You may also want to know
HUGE's Roi HUGE's Inventory Turnover Ratio HUGE's Growth Rates HUGE's Dividend Comparisons
HUGE's Profitability Ratios HUGE's Asset Turnover Ratio HUGE's Dividend Growth
HUGE's Roe HUGE's Valuation Ratios HUGE's Financial Strength Ratios HUGE's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector ROA

Date modified: 2026-06-23T19:22:26+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.